Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03888105 |
|---|---|
| Brief Title: | Assess the Anti-Tumor Activity and Safety of Odronextamab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (ELM-2) |
| First Submitted : | March 14, 2019 |
| First Submitted that Met QC Criteria : | March 20, 2019 |
| First Posted : | March 25, 2019 |
| Last Update Submitted that Met QC Criteria : | January 4, 2023 |
| Last Update Posted : | January 5, 2023 |